Abstract
The concepts of particle engineering and dosage form design have become dominant themes in pharmaceutical manufacturing. This trend is not simply a reflection of the development of new, more sophisticated manufacturing methods of particles or dispersed systems but also recognition of the importance of quality control even in more traditional manufacturing processes. However, the diversity of particle treatments, methods of particle size analysis, expression and interpretation of data, and process applications results in complicated and sometimes confusing criteria for selection, adoption, or relevance of the available techniques.
Full Text
The Full Text of this article is available as a PDF (220.8 KB).
Footnotes
This report may contain statements of opinion that are those of the author(s) and do not necessarily reflect the opinions of the American Association of Pharmaceutical Scientists, the Food and Drug Administration, or the United States Pharmacopoeia and their members.
References
- 1.Mitchell JP. Particle size analysis of aerosols from medicinal inhalers. KONA-Powder and Particle. 2000;18:41–59. doi: 10.14356/kona.2000010. [DOI] [Google Scholar]
- 2.Christopher D, Curry P, Doub W, Furnkranz K, Lavery M, Lin K, PQRI Particle Size Distribution Mass Balance Working Group et al. Considerations for the development and practice of cascade impaction testing including a mass balance failure investigation tree. J Aerosol Med. 2003;16(3):235–247. doi: 10.1089/089426803769017604. [DOI] [PubMed] [Google Scholar]
- 3.Mitchell JP. Regarding the development and practice of cascade impaction testing, including a mass balance failure investigation tree. J Aerosol Med. 2003;16(4):433–433. doi: 10.1089/089426803772455686. [DOI] [PubMed] [Google Scholar]